CSS
Cubist Systematic Strategies Portfolio holdings
AUM $9.23B
1-Year Return
5.79%
This Quarter Return
+1.05%
1 Year Return
+5.79%
3 Year Return
+24.49%
5 Year Return
+69.08%
10 Year Return
+125.75%
AUM
$6.15B
AUM Growth
-$454M
(-6.9%)
Cap. Flow
-$618M
Cap. Flow
% of AUM
-10.04%
Top 10 Holdings %
Top 10 Hldgs %
7.78%
Holding
2,467
New
616
Increased
392
Reduced
407
Closed
581
Top Buys
| 1 |
American Airlines Group
AAL
|
+$50.6M |
| 2 |
L3Harris
LHX
|
+$48.8M |
| 3 |
Booking.com
BKNG
|
+$45.6M |
| 4 |
Vertiv
VRT
|
+$45.5M |
| 5 |
Sprouts Farmers Market
SFM
|
+$40.9M |
Top Sells
| 1 |
Bank of America
BAC
|
+$83.7M |
| 2 |
Spotify
SPOT
|
+$75.7M |
| 3 |
General Motors
GM
|
+$69.7M |
| 4 |
Ferguson
FERG
|
+$52.5M |
| 5 |
Carnival Corp
CCL
|
+$49.9M |
Sector Composition
| 1 | Technology | 22.18% |
| 2 | Healthcare | 12.52% |
| 3 | Industrials | 12.24% |
| 4 | Financials | 12.23% |
| 5 | Consumer Discretionary | 11.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Jayud Global Logistics
JYD
$19.7M
| $34.3K | ﹤0.01% |
+10,728
| New | +$34.3K |
|
1352
GFL Environmental
GFL
$16.9B
| $34.3K | ﹤0.01% |
770
-14,518
| -95% | -$647K |
|
1353
Nuvectis Pharma
NVCT
$158M
| $34.1K | ﹤0.01% |
+6,294
| New | +$34.1K |
|
1354
Nautilus Biotechnolgy
NAUT
$94.8M
| $34K | ﹤0.01% |
+20,256
| New | +$34K |
|
1355
Lightpath Technologies
LPTH
$261M
| $32.4K | ﹤0.01% |
+9,180
| New | +$32.4K |
|
1356
Wallbox
WBX
$69.3M
| $32.1K | ﹤0.01% |
+3,208
| New | +$32.1K |
|
1357
AC Immune
ACIU
$256M
| $31.5K | ﹤0.01% |
11,667
-2,604
| -18% | -$7.03K |
|
1358
KORU Medical Systems
KRMD
$186M
| $29K | ﹤0.01% |
7,522
+1,181
| +19% | +$4.55K |
|
1359
PubMatic
PUBM
$385M
| $29K | ﹤0.01% |
+1,971
| New | +$29K |
|
1360
Voyager Therapeutics
VYGR
$236M
| $28.8K | ﹤0.01% |
+5,074
| New | +$28.8K |
|
1361
WM Technology
MAPS
$136M
| $27.9K | ﹤0.01% |
+20,188
| New | +$27.9K |
|
1362
Comtech Telecommunications
CMTL
$71.7M
| $27.4K | ﹤0.01% |
+6,834
| New | +$27.4K |
|
1363
Winmark
WINA
$1.8B
| $27.4K | ﹤0.01% |
70
-768
| -92% | -$300K |
|
1364
Babcock & Wilcox
BW
$324M
| $26K | ﹤0.01% |
15,838
+4,539
| +40% | +$7.44K |
|
1365
Smart Sand
SND
$78.3M
| $24.5K | ﹤0.01% |
+10,867
| New | +$24.5K |
|
1366
Context Therapeutics
CNTX
$76.1M
| $23.8K | ﹤0.01% |
+22,710
| New | +$23.8K |
|
|
OMGA
1367
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $23.6K | ﹤0.01% |
31,617
| – | – |
|
1368
Immunic
IMUX
$80.4M
| $23.3K | ﹤0.01% |
23,312
-17,750
| -43% | -$17.8K |
|
1369
Definitive Healthcare
DH
$426M
| $23.2K | ﹤0.01% |
5,644
-205,642
| -97% | -$845K |
|
|
AGEN
1370
Agenus
AGEN
$142M
| $22.9K | ﹤0.01% |
8,353
+5,281
| +172% | +$14.5K |
|
1371
Alto Ingredients
ALTO
$91.3M
| $22.6K | ﹤0.01% |
14,492
-12,247
| -46% | -$19.1K |
|
1372
Nine Energy Service
NINE
$31M
| $22.5K | ﹤0.01% |
20,069
+1,075
| +6% | +$1.2K |
|
|
WHWK
1373
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$91.9M
| $20.8K | ﹤0.01% |
6,589
+5,580
| +553% | +$17.6K |
|
|
EMX
1374
EMX Royalty
EMX
$438M
| $20.3K | ﹤0.01% |
11,733
-4,999
| -30% | -$8.65K |
|
1375
CERo Therapeutics
CERO
$6.83M
| $20K | ﹤0.01% |
+167
| New | +$20K |
|